Skip to main content
. 2020 Jul 30;10:1220. doi: 10.3389/fonc.2020.01220

Figure 3.

Figure 3

Correlation between ctDNA, clinical high-risk factors and disease relapse. (A) Disease-free survival analysis of preoperative ctDNA detection patients with PDAC. (B) Disease-free survival analysis of postoperative ctDNA detection patients with PDAC. Disease-free survival analysis of 27 patients with different clinical features, including localized /metastatic clinical stage (C), tumor largest size (D), lymph node (LM) metastasis (E), nerve invasion (F), vascular invasion (G), differentiation (H), and postoperative CA19-9 level (I).